Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 21, 2016; 22(47): 10450-10460
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10450
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10450
Table 1 Characteristics of four irritable bowel syndrome-subtypes n (%)
Characteristics | IBS (n = 105) | IBS-C (n = 23) | IBS-D (n = 42) | IBS-M (n =9) | IBS-U (n = 31) | P value |
Age (yr) (mean ± SD) | 57.1 ± 10.3 | 60.3 ± 8.7 | 54.9 ± 11.9 | 52.0 ± 9.6 | 59.3 ± 8.2 | 0.0491 |
≤ 50 | 24 (22.9) | 2 (8.7) | 12 (28.6) | 5 (55.6) | 5 (16.1) | |
51-60 | 39 (37.1) | 11 (47.8) | 14 (33.3) | 1 (11.1) | 13 (41.9) | |
61-70 | 35 (33.3) | 8 (34.8) | 13 (31.0) | 3 (33.3) | 11 (35.5) | |
≥ 71 | 7 (6.7) | 2 (8.7) | 3 (7.1) | 0 (0.0) | 2 (6.5) | |
Disease duration (yr) (mean ± SD) | 4.3 ± 5.4 | 3.0 ± 2.7 | 5.0 ± 5.7 | 6.8 ± 10.6 | 3.8 ± 4.3 | 0.247 |
< 1 | 33 (31.4) | 8 (34.8) | 11 (26.2) | 3 (33.3) | 11 (35.5) | |
1-3 | 33 (31.4) | 9 (39.2) | 13 (31.0) | 4 (44.4) | 9 (29.0) | |
3-5 | 19 (18.2) | 3 (13.0) | 8 (19.0) | 0 (0.0) | 6 (19.4) | |
> 5 | 20 (19.0) | 3 (13.0) | 10 (23.8) | 2 (22.3) | 5 (16.1) | |
Gender | < 0.0012 | |||||
Male | 37 (35.2) | 6 (26.1) | 24 (57.1) | 4 (44.4) | 3 (9.7) | |
Female | 68 (64.8) | 17 (73.9) | 18 (42.8) | 5 (55.6) | 28 (90.3) | |
Employment Status | 0.094 | |||||
Retired | 42 (40.0) | 10 (43.5) | 16 (38.1) | 3 (33.3) | 13 (41.9) | |
Employed | 63 (60.0) | 13 (56.5) | 26 (61.9) | 6 (66.7) | 8 (58.1) | |
Income level | 0.096 | |||||
Lower income | 43 (40.9) | 10 (43.5) | 15 (35.7) | 5 (55.6) | 13 (41.9) | |
Middle income | 55 (52.4) | 12 (52.2) | 25 (59.5) | 2 (22.2) | 16 (51.6) | |
Higher income | 7 (6.7) | 1 (4.3) | 2 (4.8) | 2 (22.2) | 2 (6.5) |
Table 2 Direct medical costs (CNY yuan)
Direct medical costs | No. of patients | Average visits per 4 wk | Average visits per year | 4-wk drug cost per patient | 4-wk medical cost per patient | Annual costs per patient |
Outpatient | 99 (94.29%) | 1.01 | 12.42 | 213.57 (185.86-246.95) | 112.49 (82.04-142.77) | 4266.58 (3705.55-4838.44) |
Pharmacy | 13 (12.38%) | 1.08 | 1.72 | 17.33 (7.53-28.29) | 0.76 (0.34-1.25) | 31.56 (13.74- 51.29) |
Inpatient | 105 (100%) | 0.01 | 1.28 | 290.76 (261.82-320.29) | 359.03 (340.65-377.07) | 8476.30 (7888.07-9050.18) |
Total costs | 521.67 (76.32-91.09) | 472.28 (437.26-507.22) | 12761.14 (11885.82-13595.74) |
Table 3 Direct nonmedical costs (CNY yuan)
Direct nonmedical costs | No. of patients | 4-wk costs per patient | Annual costs per patient |
Travel | 105 (100%) | 23.06 (19.65-26.57) | 749.75 (645.57-867.93) |
Meals | 98 (93.33%) | 6.49 (4.77-8.30) | 79.03 (58.16-101.00) |
Health food | 8 (7.62%) | 49.05 (14.28-97.13) | 48.75 (14.20-96.55) |
Total costs | 78.60 (42.55-127.91) | 877.54 (752.62-1022.94) |
Table 4 Indirect costs (CNY yuan)
Indirect costs | 4-wk lost work days | Average costs per 4 wk | Annual lost work days per patient | Annual costs per patient |
Outpatient | 0.62 (0.57-0.68) | 108.71 (99.60-117.84) | 8.14 (7.45-8.88) | 1337.07 (1225.06-1449.34) |
Pharmacy | 0.06 (0.03-0.10) | 10.79 (4.98-17.43) | 0.81 (0.37-1.30) | 17.42 (8.04-28.15) |
Inpatient | 1.10 (1.04-1.16) | 190.85 (180.80-202.17) | 14.29 (13.54-15.13) | 2489.59 (2358.47-1637.26) |
Resting at home | 0.34 (0.32-0.36) | 59.80 (56.87-62.98) | 4.48 (4.25-4.71) | 780.07 (741.90-821.56) |
Total costs | 2.13 (2.04-2.22) | 370.15 (355.61-386.23) | 27.71 (26.62-28.91) | 4624.15 (4456.32-4802.13) |
Table 5 Total costs (CNY yuan)
4-wk costs per patient | Annual costs per patient | |
Direct medical costs | 993.95 (934.37-1059.57) | 12761.14 (11885.82-13595.74) |
Outpatient | 326.06 (285.86-372.84) | 4266.58 (3705.55-4838.44) |
Pharmacy | 18.10 (7.77-28.25) | 31.56 (13.74- 51.29) |
Inpatient | 649.79 (601.91-693.69) | 8476.30 (7888.07-9050.18) |
Direct nonmedical costs | 78.60 (42.55-127.91) | 877.54 (752.62-1022.94) |
Travel | 23.06 (19.65-26.57) | 749.75 (645.57-867.93) |
Meals | 6.49 (4.77-8.30) | 79.03 (58.16-101.00) |
Health food | 49.05 (14.28-97.13) | 48.75 (14.20-96.55) |
Indirect costs | 370.15 (355.61-386.23) | 4624.15 (4456.32-4802.13) |
Outpatient | 108.71 (99.60-117.84) | 1337.07 (1225.06-1449.34) |
Pharmacy | 10.79 (4.98-17.43) | 17.42 (8.04-28.15) |
Inpatient | 190.85 (180.80-202.17) | 2489.59 (2358.47-1637.26) |
Resting at home | 59.80 (56.87-62.98) | 780.07 (741.90-821.56) |
Total costs | 1442.70 (1356.99-1520.09) | 18262.84 (17326.86-19158.27) |
Table 6 Total costs for the entire Chinese population
Total costs | National health budget | Costs as % of national health budget | GDP | Total costs as % of GDP | Units | |||
National | Per capita | National | Per capita | National | Per capita | |||
123.83 B (1.99 B) | 18262.84 (2933.08) | 3758.48 B (603.63 B) | 3.29% | 67670.8 B (10868.2 B) | 51560.3 (8280.8) | 0.18% | 35% | 2015CNY (2015USD) |
Table 7 Total costs of four irritable bowel syndrome subtypes (CNY yuan)
IBS-C | IBS-D | IBS-M | IBS-U | P value | |
Direct medical costs | 12036.72 (10319.41-13841.58) | 12838.55 (11570.90-14221.77) | 12990.03 (11094.74-14757.98) | 13127.30 (11484.21-14680.82) | 0.830 |
Direct nonmedical costs | 973.31 (741.98-1252.00) | 812.15 (586.09-1114.49) | 986.80 (95.42-201.77) | 863.34 (716.92-1025.52) | 0.792 |
Indirect costs | 4449.10 (4020.92-4893.99) | 4890.66 (4648.80-5169.87) | 4914.35 (4446.81-5340.35) | 4308.71 (4017.27-4584.88) | 0.0311 |
Total costs | 17459.12 (15369.32-19486.61) | 18541.36 (17241.44-19933.29) | 18891.18 (16960.86-20813.44) | 18299.35 (16423.33-20269.52) | 0.817 |
Table 8 Economic burden per person with irritable bowel syndrome in other studies
Ref. | Country | Total costs | Units | |
Direct | Indirect | |||
This study | China | 13638.68 (2190.42)1 | 4624.15 (801.64)1 | 2015CNY (2015USD) |
Dean et al[52] | United States | 7737 (10398)2 | 2005USD (2015USD) | |
Leong et al[23] | United States | 3736 (6175)2 | 791 (1307)2 | 1998USD (2015USD) |
Ricci et al[53] | United States | 7547 (11758)2 | 2000USD (2015USD) | |
Ahn et al[54] | United States | 1562 (2294)2 | 2002USD (2015USD) | |
Creed et al[55] | United Kingdom | 1743 (2634)3 | 334.50 (505.45)3 | 2003USD (2015USD) |
- Citation: Zhang F, Xiang W, Li CY, Li SC. Economic burden of irritable bowel syndrome in China. World J Gastroenterol 2016; 22(47): 10450-10460
- URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10450.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i47.10450